نتایج جستجو برای: angiotensin ii receptor antagonist

تعداد نتایج: 1164245  

Journal: :Circulation 2000
S Sakai T Miyauchi I Yamaguchi

BACKGROUND We reported that long-term (3-month) treatment with the endothelin (ET) type A (ET(A)) receptor antagonist BQ-123 markedly improved survival in rats with chronic heart failure (CHF). However, it is not known whether long-term treatment with an ET receptor antagonist improves alterations in the expression of cardiac genes in failing hearts. METHODS AND RESULTS CHF rats and control s...

Journal: :The Journal of pharmacology and experimental therapeutics 2004
Mark C Kowala Natesan Murugesan John Tellew Kenneth Carlson Hossain Monshizadegan Carol Ryan Zhengxiang Gu Bridgette Kane Leena Fadnis Rose Ann Baska Sophie Beyer Susan Arthur Kenneth Dickinson Donglu Zhang Mark Perrone Pam Ferrer Mary Giancarli Jergen Baumann Eileen Bird Balkrushna Panchal Yifan Yang Nick Trippodo Joel Barrish John E Macor

Angiotensin II and endothelin-1 activate their respective AT(1) and ET(A) receptors on vascular smooth muscle cells, producing vasoconstriction, and both peptides are implicated in the pathogenesis of essential hypertension. Angiotensin II potentiates the production of endothelin, and conversely endothelin augments the synthesis of angiotensin II. Both AT(1) and ET(A) receptor antagonists lower...

Journal: :Hypertension 2010
Elena Y Senchenkova Janice Russell Lidiana D Almeida-Paula Joseph W Harding D Neil Granger

Hypertension is associated with an increased risk of thrombosis that appears to involve an interaction between the renin-angiotensin system and hemostasis. In this study we determined whether angiotensin II-mediated thrombosis occurs in arterioles and/or venules and assessed the involvement of type 1 (AT₁), type 2 (AT₂), and type 4 (AT₄) angiotensin II receptors, as well as receptors for endoth...

Journal: :American journal of physiology. Cell physiology 2006
Patricia E Gallagher Mark C Chappell Carlos M Ferrario E Ann Tallant

Angiotensin-converting enzyme 2 (ACE2) is a homolog of ACE that preferentially forms angiotensin-(1-7) [ANG-(1-7)] from angiotensin II (ANG II). Incubation of neonatal rat cerebellar or medullary astrocytes with ANG II reduced ACE2 mRNA by approximately 60%, suggesting transcriptional regulation of the enzyme. In contrast, ANG II had no effect on ACE mRNA in astrocytes isolated from either brai...

Journal: :Hypertension 2009
Emanuela Falaschetti Moushumi Chaudhury Jennifer Mindell Neil Poulter

This study evaluate whether blood pressure management has improved in England between 2003 and 2006, using cross-sectional, nationally representative, random samples of 8834 (in 2003) and 7478 (in 2006) noninstitutionalized adults (aged > or =16 years) of mean age 46 (in 2003) and 47 (in 2006) years. Overall mean blood pressure levels in 2006 were 130.8/74.2 mm Hg in men and 124.0/72.4 mm Hg in...

Journal: :Hypertension 2012
Masaru Iwai Hirotomo Nakaoka Izumi Senba Harumi Kanno Tomozo Moritani Masatsugu Horiuchi

We explored the roles of angiotensin-converting enzyme 2 (ACE2), angiotensin-(1-7), and Mas activation in angiotensin II type 1 receptor blockade-mediated attenuation of vascular remodeling. Vascular injury was induced by polyethylene-cuff placement around the mouse femoral artery. After cuff placement, the mRNA level of both ACE2 and Mas was markedly decreased in wild-type mice, whereas ACE mR...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012
Eric M Mortensen Brandy Nakashima John Cornell Laurel A Copeland Mary Jo Pugh Antonio Anzueto Chester Good Marcos I Restrepo John R Downs Christopher R Frei Michael J Fine

BACKGROUND Studies suggest that statins and angiotensin-converting enzyme (ACE) inhibitors might be beneficial for the treatment of infections. Our purpose was to examine the association of statin, ACE inhibitor, and angiotensin II receptor blocker (ARB) use with pneumonia-related outcomes. METHODS We conducted a retrospective cohort study using Department of Veterans Affairs data of patients...

Journal: :Hypertension 2009
Karen A Griffin Anil K Bidani

Uncritical Acceptance of Combination Treatment of Angiotensin II Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor in Nondiabetic Renal Disease Trial Results To the Editor: We have just read the published editorial in the present issue of Hypertension by Kaplan1 with great interest. We very much agree with his comments and, in particular, share his concerns with respect to an uncriti...

Journal: :Hypertension 2001
J L Bascands J P Girolami M Troly I Escargueil-Blanc D Nazzal R Salvayre N Blaes

Angiotensin II regulates vascular structure through growth and apoptosis, with implications in pathophysiology. Subtypes of vascular smooth muscle cells with specific morphology, growth, or apoptotic features have been isolated. Here, we investigated the effects of angiotensin II on apoptosis of 2 morphologically different rat aortic smooth muscle cell phenotypes. Spindle and epithelioid cell l...

Journal: :Journal of the American College of Cardiology 2001
Y Oikawa K Maehara T Saito K Tamagawa Y Maruyama

OBJECTIVES We investigated the changes in coronary vascular resistance caused by angiotensin II, angiotensin-converting enzyme (ACE) inhibition and angiotensin II type 1 or 2 receptor (AT(1)R and AT(2)R, respectively) antagonists in chronic heart failure (CHF). BACKGROUND Angiotensin II is an intense vasoconstrictor, and increased angiotensin II in CHF might exert significant vasoconstriction...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید